TCRX icon

TScan Therapeutics
TCRX

Overview Fund Activity

26 hedge funds and large institutions have $29M invested in TScan Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 1 closing their positions.

Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
6
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Geode Capital Management
1
Geode Capital Management
Massachusetts
$307K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$785K
3
PFMU
3
Privium Fund Management (UK)
United Kingdom
$48K
4
Prudential Financial
4
Prudential Financial
New Jersey
$34K
5
CC
5
Cannell Capital
Wyoming
$45K

Top Sellers

1
TCM
1
Tang Capital Management
California
$1.7M
2
WP
2
Woodline Partners
California
$203K
3
NM
3
Newtyn Management
New York
$610K
4
Jane Street
4
Jane Street
New York
$0
5
TRCT
5
Tower Research Capital (TRC)
New York
$18K
Name Holding Trade Value Shares
Change 		Shares
Change %
Jane Street
26
Jane Street
New York
– -$32K -10,176 Closed
1
2